pFBOH-MHL_WDR13:142-485
(Plasmid
#210924)
-
PurposeInsect expression of human WDR13 fragment A142 to K485. N-terminal 6X His tag with TEV cleavage.
-
Depositing Lab
-
Publication
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 210924 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 * |
* Log in to view industry pricing.
Backbone
-
Vector backbonepFBOH-MHL
-
Backbone manufacturerpFASTBac1 Modified
-
Vector typeInsect Expression
-
Selectable markersGentamicin
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nameWDR13:A142-K485
-
SpeciesH. sapiens (human)
-
Insert Size (bp)1032
-
MutationH325R natural variant (VAR_060284)
-
Entrez GeneWDR13 (a.k.a. MG21, FLJ20563, DKFZp779C2057)
- Promoter Polyhedrin
-
Tag
/ Fusion Protein
- MHHHHHHSSGRENLYFQG (N terminal on insert)
Cloning Information
- Cloning method Ligation Independent Cloning
- 5′ sequencing primer tattccggattattcataccg
- 3′ sequencing primer ctctacaaatgtggtatggc (Common Sequencing Primers)
Resource Information
-
A portion of this plasmid was derived from a plasmid made byIntegrated DNA Technologies (Synthetic dsDNA)
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
Trademarks:
- Zeocin® is an InvivoGen trademark.
Depositor Comments
5' Cloning Site: BseRI (destroyed), 3' Cloning Site: BseRI (destroyed).
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pFBOH-MHL_WDR13:142-485 was a gift from Cheryl Arrowsmith (Addgene plasmid # 210924 ; http://n2t.net/addgene:210924 ; RRID:Addgene_210924) -
For your References section:
A resource to enable chemical biology and drug discovery of WDR Proteins. Ackloo S, Li F, Szewczyk M, Seitova A, Loppnau P, Zeng H, Xu J, Ahmad S, Arnautova Y, Baghaie A, Beldar S, Bolotokova A, Centrella P, Chau I, Clark M, Cuozzo J, Dehghani-Tafti S, Disch J, Dong A, Dumas A, Feng J, Ghiabi P, Gibson E, Gilmer J, Goldman B, Green S, Guié M, Guilinger J, Harms N, Herasymenko O, Houliston S, Hutchinson A, Kearnes S, Keefe A, Kimani S, Kramer T, Kutera M, Kwak H, Lento C, Li Y, Liu J, Loup J, Machado R, Mulhern C, Perveen S, Righetto G, Riley P, Shrestha S, Sigel E, Silva M, Sintchak M, Slakman B, Taylor R, Thompson J, Torng W, Underkoffler C, Rechenberg M, Watson I, Wilson D, Wolf E, Yadav M, Yazdi A, Zhang J, Zhang Y, Santhakumar V, Edwards A, Barsyte-Lovejoy D, Schapira M, Brown P, Halabelian L, Arrowsmith C. bioRxiv 2024.03.03.583197 10.1101/2024.03.03.583197